Literature DB >> 22918969

Generation and characterization of novel cytochrome P450 Cyp2c gene cluster knockout and CYP2C9 humanized mouse lines.

Nico Scheer1, Yury Kapelyukh, Lynsey Chatham, Anja Rode, Sandra Buechel, C Roland Wolf.   

Abstract

Compared with rodents and many other animal species, the human cytochrome P450 (P450) Cyp2c gene cluster varies significantly in the multiplicity of functional genes and in the substrate specificity of its enzymes. As a consequence, the use of wild-type animal models to predict the role of human CYP2C enzymes in drug metabolism and drug-drug interactions is limited. Within the human CYP2C cluster CYP2C9 is of particular importance, because it is one of the most abundant P450 enzymes in human liver, and it is involved in the metabolism of a wide variety of important drugs and environmental chemicals. To investigate the in vivo functions of cytochrome P450 Cyp2c genes and to establish a model for studying the functions of CYP2C9 in vivo, we have generated a mouse model with a deletion of the murine Cyp2c gene cluster and a corresponding humanized model expressing CYP2C9 specifically in the liver. Despite the high number of functional genes in the mouse Cyp2c cluster and the reported roles of some of these proteins in different biological processes, mice deleted for Cyp2c genes were viable and fertile but showed certain phenotypic alterations in the liver. The expression of CYP2C9 in the liver also resulted in viable animals active in the metabolism and disposition of a number of CYP2C9 substrates. These mouse lines provide a powerful tool for studying the role of Cyp2c genes and of CYP2C9 in particular in drug disposition and as a factor in drug-drug interaction.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22918969     DOI: 10.1124/mol.112.080036

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  14 in total

1.  Contributions of the three CYP1 monooxygenases to pro-inflammatory and inflammation-resolution lipid mediator pathways.

Authors:  Senad Divanovic; Jesmond Dalli; Lucia F Jorge-Nebert; Christopher L Karp; Charles N Serhan; Daniel W Nebert; Leah M Flick; Marina Gálvez-Peralta; Nicholas D Boespflug; Traci E Stankiewicz; Jonathan M Fitzgerald; Maheshika Somarathna
Journal:  J Immunol       Date:  2013-08-16       Impact factor: 5.422

Review 2.  P450-Humanized and Human Liver Chimeric Mouse Models for Studying Xenobiotic Metabolism and Toxicity.

Authors:  Karl-Dimiter Bissig; Weiguo Han; Mercedes Barzi; Nataliia Kovalchuk; Liang Ding; Xiaoyu Fan; Francis P Pankowicz; Qing-Yu Zhang; Xinxin Ding
Journal:  Drug Metab Dispos       Date:  2018-08-09       Impact factor: 3.922

3.  Regulation of bile acid metabolism in mouse models with hydrophobic bile acid composition.

Authors:  Akira Honda; Teruo Miyazaki; Junichi Iwamoto; Takeshi Hirayama; Yukio Morishita; Tadakuni Monma; Hajime Ueda; Seiya Mizuno; Fumihiro Sugiyama; Satoru Takahashi; Tadashi Ikegami
Journal:  J Lipid Res       Date:  2019-10-23       Impact factor: 5.922

4.  Opioid Analgesia in P450 Gene Cluster Knockout Mice: A Search for Analgesia-Relevant Isoforms.

Authors:  Lindsay B Hough; Julia W Nalwalk; Xinxin Ding; Nico Scheer
Journal:  Drug Metab Dispos       Date:  2015-06-24       Impact factor: 3.922

Review 5.  Human cytochromes P450 in health and disease.

Authors:  Daniel W Nebert; Kjell Wikvall; Walter L Miller
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2013-01-06       Impact factor: 6.237

Review 6.  Animal models to study bile acid metabolism.

Authors:  Jianing Li; Paul A Dawson
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2018-05-18       Impact factor: 5.187

7.  Effects of MicroRNA-34a on the Pharmacokinetics of Cytochrome P450 Probe Drugs in Mice.

Authors:  Joseph L Jilek; Ye Tian; Ai-Ming Yu
Journal:  Drug Metab Dispos       Date:  2017-03-02       Impact factor: 3.922

8.  Characterization of the Tissue Distribution of the Mouse Cyp2c Subfamily by Quantitative PCR Analysis.

Authors:  Joan P Graves; Artiom Gruzdev; J Alyce Bradbury; Laura M DeGraff; Matthew L Edin; Darryl C Zeldin
Journal:  Drug Metab Dispos       Date:  2017-04-27       Impact factor: 3.922

9.  Cyp2c70 is responsible for the species difference in bile acid metabolism between mice and humans.

Authors:  Shogo Takahashi; Tatsuki Fukami; Yusuke Masuo; Chad N Brocker; Cen Xie; Kristopher W Krausz; C Roland Wolf; Colin J Henderson; Frank J Gonzalez
Journal:  J Lipid Res       Date:  2016-09-16       Impact factor: 5.922

10.  A role for cytochrome b5 in the In vivo disposition of anticancer and cytochrome P450 probe drugs in mice.

Authors:  Colin J Henderson; Lesley A McLaughlin; Robert D Finn; Sebastien Ronseaux; Yury Kapelyukh; C Roland Wolf
Journal:  Drug Metab Dispos       Date:  2013-10-10       Impact factor: 3.922

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.